|Bid||183.58 x 900|
|Ask||190.00 x 1000|
|Day's Range||188.21 - 193.37|
|52 Week Range||184.48 - 336.99|
|Beta (5Y Monthly)||1.44|
|PE Ratio (TTM)||14.23|
|Earnings Date||Feb 23, 2022 - Feb 28, 2022|
|Forward Dividend & Yield||5.68 (2.99%)|
|Ex-Dividend Date||Dec 20, 2021|
|1y Target Est||348.00|
Subscribe to Yahoo Finance Plus to view Fair Value for MEDLearn more
Altria Group's (MO) fourth-quarter 2021 results reflect an increased bottom line, while the top line declines year over year. Pricing remains an upside.
McCormick's (MKC) fourth-quarter fiscal 2021 results reflect the impact of higher sales driven by growth in the Flavor Solutions and Consumer units. Also, earnings increase in the quarter.
Medifast (MED) has been benefiting from the strength of its OPTAVIA lifestyle solution and coaching support system, as well as efficient technological investments.